Delivery Order SPE2DB20D3104-SPE2DB24FV9F4
Award Date
9/5/24
Potential Completion Date
9/26/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,613.50 firm fixed price delivery order is for the supply of 200-unit vials of BOTOX. The contract has a completion date of January 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,078.75 firm-fixed-price delivery order is for the supply of 200-unit vials of BOTOX. The contract has an ultimate completion date of January 3, 2025 and was awarded on December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,437.28 firm-fixed-price delivery order is for the supply of 100-unit vials of Botox, a specialty medication. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,564.37 firm fixed price delivery order is for the provision of 200 unit vials of BOTOX. The contract has an ultimate completion date of February 13, 2025 and was awarded on January 23, 2025. This appears to be a delivery order placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,011.25 firm fixed-price delivery order is for the supply of 200-unit vials of Botox, a pharmaceutical medication. The contract has a ceiling value of $3,011.25 and an ultimate completion date of December 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,913.36 Firm Fixed Price delivery order is for the supply of 200 unit vials of BOTOX. The contract has an ultimate completion date of November 18, 2024. This award is a task order under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,478.34 firm fixed-price delivery order is for the supply of 200-unit vials of the medication BOTOX. The contract has a completion date of September 3, 2024 and was awarded on August 12, 2024. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,547.90 firm fixed-price delivery order is for the supply of 200-unit vials of Botox medication. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,296.60 firm fixed-price delivery order is for the procurement of 100-unit vials of BOTOX medication, with a completion date of December 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,311.84 firm fixed-price delivery order is for the supply of 100-unit vials of BOTOX, a specialty medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...